| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/07/2013 | CA2846852A1 Fap-activated proteasome inhibitors for treating solid tumors |
| 03/07/2013 | CA2846845A1 Methods and compositions for promoting glucose homeostasis |
| 03/07/2013 | CA2846413A1 Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
| 03/07/2013 | CA2846387A1 Methods for treating cardiovascular disorders |
| 03/07/2013 | CA2846287A1 Stable peptide-based pace4 inhibitors |
| 03/07/2013 | CA2846248A1 Method for inhibiting cellular activation by insulin-like growth factor-1 |
| 03/07/2013 | CA2846030A1 Vegf-specific capture agents, compositions and methods of using and making |
| 03/07/2013 | CA2845663A1 Cyclosporin derivatives |
| 03/07/2013 | CA2845357A1 Method of treating or ameliorating type 1 diabetes using fgf21 |
| 03/07/2013 | CA2844510A1 Method for the preparation of a heat stable oxygen carrier-containing composition facilitating beta-beta cross-linking |
| 03/07/2013 | CA2844464A1 Methods for treating properdin-related diseases or disorders |
| 03/07/2013 | CA2842133A1 Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| 03/06/2013 | EP2565275A1 Method of treatment of vascular complications using modulators of TRX and TRXNIP |
| 03/06/2013 | EP2565269A1 High-purity soluble thrombomodulin and method for producing same |
| 03/06/2013 | EP2565205A1 Glucagon-like peptide-1 analogue and use thereof |
| 03/06/2013 | EP2565202A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability |
| 03/06/2013 | EP2565201A1 WT1 HLA class II-binding peptides and compositions and methods comprising same |
| 03/06/2013 | EP2564870A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 03/06/2013 | EP2564866A2 Pharmaceutical composition using connective tissue growth factor |
| 03/06/2013 | EP2564865A1 Methods of Modulating Cellular Homeostatic Pathways and Cellular Survival |
| 03/06/2013 | EP2564864A2 FGF2-related methods for diagnosing and treating depression |
| 03/06/2013 | EP2564863A2 Triazole linked macrocyclic peptides |
| 03/06/2013 | EP2564853A1 Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders |
| 03/06/2013 | EP2563918A1 Genome editing of a rosa locus using zinc-finger nucleases |
| 03/06/2013 | EP2563912A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases |
| 03/06/2013 | EP2563911A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
| 03/06/2013 | EP2563910A1 Enzyme granules |
| 03/06/2013 | EP2563809A2 Stable aqueous mia/cd-rap formulations |
| 03/06/2013 | EP2563808A1 Peptide conjugates of glp-1 receptor agonists and gastrin and their use |
| 03/06/2013 | EP2563807A1 Polypeptide expressed in the stratum corneum and use thereof |
| 03/06/2013 | EP2563452A2 Composite microneedle array including nanostructures thereon |
| 03/06/2013 | EP2563406A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
| 03/06/2013 | EP2563403A1 Conjugated blood coagulation factor viia |
| 03/06/2013 | EP2563402A1 Conjugated blood coagulation factor viii |
| 03/06/2013 | EP2563398A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans |
| 03/06/2013 | EP2563385A1 Methods of use of soluble cd24 for therapy of rheumatoid arthritis |
| 03/06/2013 | EP2563384A2 Immunogenic compositions and methods for treating neoplasia |
| 03/06/2013 | EP2563383A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| 03/06/2013 | EP2563382A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases |
| 03/06/2013 | EP2563381A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases |
| 03/06/2013 | EP2563380A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
| 03/06/2013 | EP2563379A1 Sox9 inhibitors |
| 03/06/2013 | EP2563378A1 Pea protein peptides with anti helicobacter pylori activity |
| 03/06/2013 | EP2563369A2 Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof |
| 03/06/2013 | EP2563361A1 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 03/06/2013 | EP2395015B1 Peptides for wound healing |
| 03/06/2013 | CN102959087A Compositions for linking zinc finger modules |
| 03/06/2013 | CN102958533A Dipeptide linked medicinal agents |
| 03/06/2013 | CN102958532A Pharmaceutical composition using connective tissue growth factor |
| 03/06/2013 | CN102958531A High affinity leptins and leptin antagonists |
| 03/06/2013 | CN102958530A Blockade of CCL18 signaling via CCR6 as therapeutic option in fibrotic diseases and cancer |
| 03/06/2013 | CN102958512A Controlled-released peptide formulations |
| 03/06/2013 | CN102958503A SIRTUIN-6-activating peptides, and cosmetic or pharmaceutical compositions including same |
| 03/06/2013 | CN102952849A Application of protein coded by gene LIMG and antibody thereof in breast cancer diagnosis and/or treatment |
| 03/06/2013 | CN102952839A Method for extracting Tuna collagen solution and product thereof |
| 03/06/2013 | CN102952838A Preparation method of immune-enhancing mussel enzymatic hydrolytic polypeptide and preparation method of corresponding tablet thereof |
| 03/06/2013 | CN102952788A Turbot C type lysozyme and building and application method thereof |
| 03/06/2013 | CN102952192A Fusion protein containing Exendin-4 and application thereof |
| 03/06/2013 | CN102952186A Peptide complex, pharmaceutical composition thereof, and preparation and application thereof |
| 03/06/2013 | CN102952185A Novel defensin pdBD, and gene and application thereof |
| 03/06/2013 | CN102952184A Application of antineoplastic activity protein TB-1 in preparation of antineoplastic drugs |
| 03/06/2013 | CN102952177A Odorrana tiannanensis natural antioxidant peptide reconstructed body and preparation method and application thereof |
| 03/06/2013 | CN102952173A Preparation method of new polypeptide with tissue protection activity and application in treatment of bovine mastitis |
| 03/06/2013 | CN102949732A Medicine fusion specifically bound with human angiopoietin-2 |
| 03/06/2013 | CN102949731A Medicine fusion specifically bound with GLP-2 receptor |
| 03/06/2013 | CN102949730A Drug fusant of specific binding GLP-1 (Glucagon-like peptide-1) receptor |
| 03/06/2013 | CN102949722A Novel pharmaceutical composition based on p38 inhibitor and cell growth factor |
| 03/06/2013 | CN102949712A Chinese and western composite medicine for treating neoplastic diseases |
| 03/06/2013 | CN102949711A Novel difunctional enzyme for promoting growth and development of bones and targeting abnormal development of bones |
| 03/06/2013 | CN102949710A Pharmaceutical composition or healthcare product for increasing bone mineral density and preparation method of pharmaceutical composition or healthcare product |
| 03/06/2013 | CN102949709A External gel used for treating diabetic foot, and preparation method and application thereof |
| 03/06/2013 | CN102949708A Application of human sDR5 (soluble death receptor 5) protein or sDR5-Fc (fragment crystallizable) antibody fusion protein as pharmaceutical drugs for myocardial infarction |
| 03/06/2013 | CN102949707A Treatment on inflammation caused by respiratory syncytial virus by developing flammulina velutipes immune adjustment proteins and lucid ganoderma immune adjustment proteins and reduction of virus dosage |
| 03/06/2013 | CN102949706A In-situ hemostatic containing desmopressin |
| 03/06/2013 | CN102949362A Orally-taken solid medicinal composition containing trandolapril and preparation method thereof |
| 03/06/2013 | CN102949356A Thymalfasin-containing freeze-dried preparation |
| 03/06/2013 | CN102949348A Enramycin dry suspension and preparation method thereof |
| 03/06/2013 | CN102949345A Recombinant human epidermal growth factor cationic liposome and preparation method thereof |
| 03/06/2013 | CN102948429A Livin bacteria removing liquid for marine organism |
| 03/06/2013 | CN102579347B Thymalfasin liposome preparation for injecting |
| 03/06/2013 | CN102250255B Genetic engineering protein TAT-VP28-GH capable of resisting white spot syndrome virus (WSSV) as well as preparation and application thereof |
| 03/06/2013 | CN102225206B Composite for enhancing transdermal administration and application thereof |
| 03/06/2013 | CN102205113B Novel application of Jingzhaotoxin |
| 03/06/2013 | CN102178662B Insulin carrier transdermal drug delivery preparation and preparation method thereof |
| 03/06/2013 | CN102174083B Compositae cyclopeptide, immunosuppressive medicine using compositae cyclopeptide as active ingredient and preparation method and application of compositae cyclopeptide |
| 03/06/2013 | CN102078592B Application of toad peptide antibiotics in preparing drugs for treating acnes |
| 03/06/2013 | CN101983968B Preparation method of sepia oligopeptide by enzymatic hydrolysis |
| 03/06/2013 | CN101884783B Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof |
| 03/06/2013 | CN101843892B Medicament composition comprising Enalapril quick-releasing part and felodipine slow-releasing part |
| 03/06/2013 | CN101827603B Methods of generating, repairing and/or maintaining connective tissue in vivo |
| 03/06/2013 | CN101812127B Microtubule-associated protein and coding genes and application thereof |
| 03/06/2013 | CN101658676B Novel cell targeted medicine delivery carrier, medicine composition containing same and method for delivering medicine by same |
| 03/06/2013 | CN101573134B Candidates against infection |
| 03/06/2013 | CN101528251B Agent comprising G-CSF for prevention and treatment of diabetic peripheral neuropathy |
| 03/06/2013 | CN101522202B Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 03/06/2013 | CN101511868B Exendin fusion proteins |
| 03/06/2013 | CN101374540B Purpose of TPO peptide compound and medicament composition for treating anaemia |
| 03/06/2013 | CN101190329B Medicinal composition for regrouping human P43 protein and its application in medication |
| 03/06/2013 | CN101108246B Thymus gland pentapeptide oral intestine-dissolved formulated product and method of preparing the same and use thereof |
| 03/06/2013 | CN101010101B Composition comprising protein material and non-oxidizable fatty acid entities |